Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001558370-25-006515
Filing Date
2025-05-06
Accepted
2025-05-06 16:32:43
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3/A xlo-20250506xs3a.htm S-3/A 616852
2 EX-23.1 xlo-20250506xex23d1.htm EX-23.1 3795
3 GRAPHIC xlo-20250506xs3a001.jpg GRAPHIC 17829
4 GRAPHIC xlo-20250506xs3a002.jpg GRAPHIC 12404
5 GRAPHIC xlo-20250506xs3a004.jpg GRAPHIC 11446
  Complete submission text file 0001558370-25-006515.txt   679492
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-285703 | Film No.: 25917797
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)